BridgeBio Pharma (BBIO) Change in Inventory (2025 - 2026)
BridgeBio Pharma (BBIO) posted Change in Inventory of $7.1 million for Q1 2026, up 261.51% sequentially from $2.0 million in Q4 2025, and up 120.89% YoY from $3.2 million in Q1 2025.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Change in Inventory (2025 - 2026) Analysis & Trends
BridgeBio Pharma has reported Change in Inventory for 2 years, with the latest figure at $7.1 million in Q1 2026.
- Quarterly Change in Inventory rose 120.89% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.2 million (up 813.47% YoY) and the FY2025 annual result came in at $25.3 million, changed N/A from the prior year.
- Change in Inventory rose to $7.1 million in Q1 2026 per BBIO's latest filing, from $2.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $13.4 million in Q2 2025 and troughed at $2.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | BridgeBio Pharma | 14.65 Bn | 13.93 Bn | 228.63 Mn | 21.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.11 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 13.39 Mn |
| Mar 31, 2025 | 3.19 Mn |